BR112023025387A2 - Usos de tirzepatida - Google Patents
Usos de tirzepatidaInfo
- Publication number
- BR112023025387A2 BR112023025387A2 BR112023025387A BR112023025387A BR112023025387A2 BR 112023025387 A2 BR112023025387 A2 BR 112023025387A2 BR 112023025387 A BR112023025387 A BR 112023025387A BR 112023025387 A BR112023025387 A BR 112023025387A BR 112023025387 A2 BR112023025387 A2 BR 112023025387A2
- Authority
- BR
- Brazil
- Prior art keywords
- sleep apnea
- obstructive sleep
- tirzepatide
- delaying
- treating
- Prior art date
Links
- BTSOGEDATSQOAF-SMAAHMJQSA-N tirzepatide Chemical compound CC[C@H](C)[C@@H](C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](C(O)=O)NC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)C(N[C@@H](C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(NCC(NCC(N(CCC1)[C@@H]1C(N[C@@H](CO)C(N[C@@H](CO)C(NCC(N[C@@H](C)C(N(CCC1)[C@@H]1C(N(CCC1)[C@@H]1C(N(CCC1)[C@@H]1C(N[C@@H](CO)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CC(C)C)NC(C(C)(C)NC([C@H]([C@@H](C)CC)NC([C@H](CO)NC([C@H](CC(C=C1)=CC=C1O)NC([C@H](CC(O)=O)NC([C@H](CO)NC([C@H]([C@@H](C)O)NC([C@H](CC1=CC=CC=C1)NC([C@H]([C@@H](C)O)NC(CNC([C@H](CCC(O)=O)NC(C(C)(C)NC([C@H](CC(C=C1)=CC=C1O)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O BTSOGEDATSQOAF-SMAAHMJQSA-N 0.000 title abstract 2
- 229940121512 tirzepatide Drugs 0.000 title abstract 2
- 108091004331 tirzepatide Proteins 0.000 title abstract 2
- 208000001797 obstructive sleep apnea Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
usos de tirzepatida. a presente invenção refere-se a métodos para tratar, prevenir ou retardar transtornos relacionados com apneia obstrutiva do sono. a presente invenção refere-se a métodos para tratar, prevenir ou retardar apneia obstrutiva do sono. proporciona um método de tratamento para apneia obstrutiva do sono.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214975P | 2021-06-25 | 2021-06-25 | |
| PCT/US2022/034212 WO2022271611A1 (en) | 2021-06-25 | 2022-06-21 | Methods for treating obstructive sleep apnea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025387A2 true BR112023025387A2 (pt) | 2024-02-27 |
Family
ID=84544725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025387A BR112023025387A2 (pt) | 2021-06-25 | 2022-06-21 | Usos de tirzepatida |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4358951A1 (pt) |
| KR (1) | KR20240027045A (pt) |
| CN (1) | CN117750953A (pt) |
| AU (1) | AU2022298632A1 (pt) |
| BR (1) | BR112023025387A2 (pt) |
| CA (1) | CA3223121A1 (pt) |
| IL (1) | IL309623A (pt) |
| WO (1) | WO2022271611A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202140058A (zh) * | 2020-01-30 | 2021-11-01 | 美商美國禮來大藥廠 | 提派肽（ｔｉｒｚｅｐａｔｉｄｅ）之治療用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201833132A (zh) * | 2016-12-02 | 2018-09-16 | 法商賽諾菲公司 | 作為肽類ｇｌｐ１／升糖素／ｇｉｐ三重受體激動劑之新穎化合物 |
| JP2021533094A (ja) * | 2018-07-23 | 2021-12-02 | イーライ リリー アンド カンパニー | 療法のためｇｉｐ／ｇｌｐ１コアゴニストを使用する方法 |
| WO2020102351A1 (en) * | 2018-11-16 | 2020-05-22 | Cymabay Therapeutics, Inc. | Treatment of obesity and its complications |
-
2022
- 2022-06-21 WO PCT/US2022/034212 patent/WO2022271611A1/en active Application Filing
- 2022-06-21 CA CA3223121A patent/CA3223121A1/en active Pending
- 2022-06-21 CN CN202280045190.1A patent/CN117750953A/zh active Pending
- 2022-06-21 AU AU2022298632A patent/AU2022298632A1/en active Pending
- 2022-06-21 BR BR112023025387A patent/BR112023025387A2/pt unknown
- 2022-06-21 KR KR1020247002954A patent/KR20240027045A/ko unknown
- 2022-06-21 EP EP22829094.6A patent/EP4358951A1/en active Pending
- 2022-06-21 IL IL309623A patent/IL309623A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022271611A1 (en) | 2022-12-29 |
| AU2022298632A1 (en) | 2023-12-14 |
| IL309623A (en) | 2024-02-01 |
| EP4358951A1 (en) | 2024-05-01 |
| KR20240027045A (ko) | 2024-02-29 |
| AU2022298632A9 (en) | 2024-01-25 |
| CN117750953A (zh) | 2024-03-22 |
| CA3223121A1 (en) | 2022-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20247617B (en) | Methods and compositions for treating sleep apnea | |
| PH12019502723A1 (en) | Methods and compositions for treating excessive sleepiness | |
| NZ750290A (en) | Amino pyrimidine ssao inhibitors | |
| BR112021017831A2 (pt) | Derivados heteroaromáticos e aromáticos heterobicíclicos para o tratamento de distúrbios relacionados com ferroptose | |
| EA201891374A1 (ru) | Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение | |
| MX2019009501A (es) | Compuestos de amino piridina utiles como inhibidores de ssao. | |
| WO2020086726A3 (en) | Nerve stimulation for treating migraine and other headache conditions | |
| WO2016176279A8 (en) | Uses of cannabidiol for treatment of infantile spasms | |
| ATE427118T1 (de) | Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd | |
| NZ750817A (en) | Treatment and prevention of sleep disorders | |
| PH12019501408A1 (en) | Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy | |
| UY38670A (es) | Inhibidores de dihidroorotato deshidrogenasa | |
| WO2019040106A3 (en) | COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES | |
| BRPI0721088B8 (pt) | processo para a preparação de derivados de piperazinil e diazepanil benzamida | |
| BR112023025387A2 (pt) | Usos de tirzepatida | |
| BR112017025263A2 (pt) | método para o tratamento de doença neurológica | |
| EA202190842A1 (ru) | Антагонисты 2-адренорецептора подтипа с (альфа-2с адренорецепторов) для лечения апноэ во сне | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
| MX2020005545A (es) | Compuestos para el tratamiento de trastornos neuromusculares. | |
| MX2021012248A (es) | Polimorfos de voruciclib y metodos de elaboracion y uso de los mismos. | |
| MX2021011269A (es) | Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina. | |
| MX2018009662A (es) | Metodo y composicion farmaceutica para tratamiento de neurodegeneracion. | |
| EA201892098A1 (ru) | Соединение, обладающее ингибирующей мутантную idh активностью, способ его получения и применения | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| CR20210277A (es) | Proceso para la producción de formas farmacéuticas que contienen inhibidores de los canales task-1 y task-3 y su uso para la terapia de trastornos respiratorios |